Zimmer Biomet Holdings has named Jonathan Vigdorchik, MD, as chief science, technology and medical affairs officer, effective April 14.
Dr. Vigdorchik will oversee the company’s global technology portfolio, including AI, robotics, smart implants and data, as well as its medical education strategy and global advisory board, according to an April 7 news release.
He previously served as Zimmer Biomet’s chief medical technology advisor for adult reconstruction and hip implants. He will report to Ivan Tornos, chairman, president and CEO.
Dr. Vigdorchik is also an orthopedic surgeon at Hospital for Special Surgery in New York City, where he specializes in hip and knee replacement surgery.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
